Biotech uses Apple Watch to study Parkinson's drug
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- A biotech company is utilizing Apple Watch for studying its Parkinson's drug, indicating a move towards digital health tools in clinical trials.
- The STAT Health Tech newsletter highlights this development alongside physician perspectives on AI and a drug giant's investment in AI chips, showcasing broader trends in health technology.
- Wearable technology is being adopted to collect richer, continuous data, which could offer deeper insights into drug performance outside traditional clinical settings.
Why it matters: Wearables in drug trials could revolutionize Parkinson's research, offering hope for faster, more effective treatments.
Ask SkimNews
